• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALYDIA HEALTH JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALYDIA HEALTH JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Model Number JADA-1001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Event Description
This spontaneous report was received from a female patient of unknown age referring to herself, via company representative.The patient's historical condition included cesarean section.The patient's concurrent conditions, concomitant medications, and past drugs/allergies were not reported.This report involves 1 patient and 1 device.On (b)(6) 2022, the patient was inserted with vacuum-induced hemorrhage control system (jada system) (strength, lot# and expiration date were not reported) for atony related bleeding.The patient had atony related bleeding postoperative cesarean section, which was in recovery, blood loss was about 2400 milliliter (ml).When vacuum-induced hemorrhage control system (jada system) was placed in the operation room (or).The patient then continued to bleed with vacuum-induced hemorrhage control system (jada system) in place and on vacuum, with a return of about 1600 ml more blood (device ineffective).The patient then had a hysterectomy to control bleeding and received multiple doses of blood products.The patient body mass index (bmi) was 48 (units not reported).The patient sought medical attention.Estimated total blood loss at delivery was reported as 4000 ml.Upon internal review, the event device ineffective was determined to be serious due to medically significant and required intervention (devices).Medical device reporting criteria: serious injury.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ALYDIA HEALTH
3495 edison way menlo park
CA 94025
Manufacturer (Section G)
ALYDIA HEALTH
3495 edison way menlo park
CA 94025
Manufacturer Contact
3495 edison way menlo park
MDR Report Key15080306
MDR Text Key296374771
Report Number3017425145-2022-00121
Device Sequence Number1
Product Code OQY
UDI-Device Identifier00850017882003
UDI-Public(01)00850017882003
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 07/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberJADA-1001
Device Catalogue NumberJADA-1001
Initial Date Manufacturer Received 06/24/2022
Initial Date FDA Received07/21/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient SexFemale
-
-